Extracellular Vesicles as Drug Delivery System for Cancer Therapy
Pharmaceutics · 01.08.2024 · 16 (8) · 1029
DOI: 10.3390/pharmaceutics16081029 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 01.08.2024. Verfasst von Jin Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Liaoning University, Shenyang 110036, China. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Liaoning Province, Doctor Research Initiation Program of Liaoning Province, Talent Introduction Research Startup Funding of Liaoning University.
Abstract (Originalsprache)
In recent decades, the pursuit of drug delivery systems has led to the development of numerous synthetic options aimed at enhancing drug efficacy while minimizing side effects. However, the practical application of these systems is often hindered by challenges such as inefficiency, cytotoxicity, and immunogenicity. Extracellular vesicles, natural carriers for drugs, emerge as promising alternatives with distinct advantages over synthetic carriers. Notably, EVs exhibit biocompatibility, low immunogenicity, and inherent tissue-targeting capabilities, thus opening new avenues for drug delivery strategies. This review provides an overview of EVs, including their biogenesis and absorption mechanisms. Additionally, we explore the current research efforts focusing on harnessing their potential as drug carriers, encompassing aspects such as purification techniques, drug loading, and bioengineering for targeted delivery. Finally, we discuss the existing challenges and future prospects of EVs as therapeutic agents in clinical settings. This comprehensive analysis aims to shed light on the potential of EVs as versatile and effective tools for drug delivery, particularly in the realm of cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences, Liaoning University, Shenyang 110036, China.
- Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, Shenyang 110001, China.
- Institute of Health Sciences, China Medical University, 77 Puhe Road, Shenyang 110122, China.
ORCID-Profile: Jin Wang
Förderung
- Natural Science Foundation of Liaoning Province
- Doctor Research Initiation Program of Liaoning Province
- Talent Introduction Research Startup Funding of Liaoning University
Zitieren
APA
Wang, J., Yin, B., Lian, J., & Wang, X. (2024). Extracellular Vesicles as Drug Delivery System for Cancer Therapy. Pharmaceutics, 16(8), 1029. https://doi.org/10.3390/pharmaceutics16081029
Vancouver
Wang J, Yin B, Lian J, Wang X. Extracellular Vesicles as Drug Delivery System for Cancer Therapy. Pharmaceutics. 2024;16(8):1029. doi:10.3390/pharmaceutics16081029
BibTeX
@article{Wang2024,
author = {Wang, Jin and Yin, Bohang and Lian, Jiabing and Wang, Xia},
title = {Extracellular Vesicles as Drug Delivery System for Cancer Therapy},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {8},
pages = {1029},
doi = {10.3390/pharmaceutics16081029}
}
EUVIMED